Top

Intensive Care Medicine

Published in:

01-12-2003 | Original

Temporal changes in muscle glutathione in ICU patients

Authors: U. B. Fläring, O. E. Rooyackers, J. Wernerman, F. Hammarqvist

Published in: Intensive Care Medicine | Issue 12/2003

Abstract

Objective

This study investigated the changes over time in glutathione and its constituent amino acids in skeletal muscle of ICU patients with multiple organ failure.

Design and setting

Prospective and descriptive pilot study in two medium-sized ICUs with ten beds.

Patients

Critically ill patients (n=10) with multiple organ failure and with an expected ICU stay longer than 6 days were included during their initial 3 days after admission to the ICU.

Measurements and results

Muscle biopsy and blood samples were taken on days 0, 3, and 6 after inclusion and total, reduced, and oxidized glutathione and the related amino acids were determined. During the study period both total and reduced glutathione increased and was in the normal range on day 6. The constituent amino acids normalized during the study period as well.

Conclusions

This pilot study demonstrates a recovery of muscle glutathione concentrations in critically ill patients with ongoing multiple organ failure within 1 week. Restoration of muscle glutathione seems to be a biological process of high priority in this group of patients.

Keller GA, Barke R, Harty JT, Humphrey E, Simmons RL (1985) Decreased hepatic glutathione levels in septic shock. Arch Surg 120:941–945CrossRef

Leff J, Parsons P, Day C, Moore F, Repine J (1993) Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341:777–780CrossRef

Pacht ER, Timerman AP, Lykens MG, Merola AJ (1991) Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100:1397–1403CrossRef

Metnitz GH, Fischer M, Bartens C, Steltzer H, Lang T, Druml W (2000) Impact of acute renal failure on antioxidant status in multiple organ failure. Acta Anaesthesiol Scand 44:236–240CrossRef

Taylor DE, Piantadosi CA (1995) Oxidative metabolism in sepsis and sepsis syndrome. J Crit Care 10:122–135CrossRef

Beutler E (1989) Nutritional and metabolic aspects of glutathione. Annu Rev Nutr 9:287–302CrossRef

Meister A (1991) Glutathione deficiency produced by inhibitors of its synthesis and its reversal: applications in research and therapy. Pharmacol Ther 51:155–194CrossRef

Tischler ME, Fagan JM (1982) Relationship of the reduction-oxidation state to protein degradation in skeletal and atrial muscle. Arch Biochem Biophys 217:191–201CrossRef

Hammarqvist F, Luo J-L, Andersson K, Wernerman J (1997) Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med 25:78–84CrossRef

10.

Corbucci GG, Gasparetto A, Candiani A, Crimi G, Antonelli M, Bufi M, De Blasi RA, Cooper MB, Gohil K (1985) Shock-induced damage to mitochondrial function and some cellular antioxidant mechanisms in humans. Circ Shock 15:15–26PubMed

11.

Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219–223CrossRef

12.

Wilmore DW, Preston R, Muhlbacher F (1983) Injured man: Trauma and sepsis. In: Winters RW, Green HL (eds) Nutritional support of the seriously ill patients. Academic, London, pp 33–52

13.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRef

14.

Vincent J-L, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRef

15.

Le Gall JR, Leneshow S, Saulnier F (1993) A New Simplified Acute Physiology Score (SAPS 2) Based on a European/North American multicenter study. JAMA 270:2957–2963CrossRef

16.

Bergström J (1962) Muscle electrolytes in man. Scand J Clin Lab Invest. 168:11–14

17.

Fläring UB, Rooyackers OE, Hammarqvist F, Wernerman J (2003) Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci (Colch) 104:275–282

18.

Hammarqvist F, Luo J-L, Andersson K, Wernerman J (1995) Glutathione and amino acid concentrations in ICU-patients. JPEN J Parenter Enteral Nutr 19:19S

19.

Luo J-L, Hammarqvist F, Andersson K, Wernerman J (1996) Skeletal muscle glutathione after surgical trauma. Ann Surg 223:420–427CrossRef

20.

Wennström I, Wernerman J, Hammarqvist F (1999) Postoperative effects of growth hormone and insulin-like growth factor-1 on the nitrogen balance and muscle amino acid pattern. Clin Nutr 18 [Suppl 1]:14

21.

Westman B, Hammarqvist F, Johansson G, Luo J-L, Söderlund K, Wernerman J (1999) Effects of ischaemia and reperfusion on glutathione and energy content in skeletal muscle during elective surgery of abdominal aortic aneurysm. Clin Nutr 18 [Suppl 1]:2

22.

Meister A (1988) Glutathione metabolism and its selective modification. J Biol Chem 25:17205–17208CrossRef

23.

Vesali RF, Klaude M, Rooyackers OE, Tjäder I, Barle H, Wernerman J (2002) Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients. Clin Nutr 21:505–514CrossRef

24.

Gamrin L, Essén P, Hultman E, Wernerman J (1996) A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy rich phosphates, protein, nucleic acids, fat, water and electrolytes. Crit Care Med 24:575–583CrossRef

25.

Pettilä V, Pettilä M, Sarna S, Voutilainen P, Takkunen O (2002) Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill. Crit Care Med 30:1705–1711CrossRef

26.

Kvåle R, Flaaten H (2002) Changes in intensive care from 1987 to 1997—has outcome improved? A single centre study. Intensive Care Med 28:1110–1116CrossRef

Title: Temporal changes in muscle glutathione in ICU patients
Authors: U. B. Fläring
O. E. Rooyackers
J. Wernerman
F. Hammarqvist
Publication date: 01-12-2003
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 12/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-2031-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Temporal changes in muscle glutathione in ICU patients

Abstract

Objective

Design and setting

Patients

Measurements and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design and setting

Patients

Measurements and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2003

Marked reduction of brainstem blood flow in artificially ventilated newborn piglets during normoxia and normocapnic hypoxia

Electrical impedance tomography: a method for monitoring regional lung aeration and tidal volume distribution?

End of life care in Canada after a murder charge in an ICU

Evaluation and management of decompression illness—an intensivist’s perspective

Critically ill old and the oldest-old patients in intensive care: short- and long-term outcomes

The relationship between labour cost per patient and the size of intensive care units: a multicentre prospective study